PAAS.TO (PAAS.TO)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 7/9, Altman Z 7.5 (above 3.0 safe zone threshold). Beneish M-Score of 1.16 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency presents a notable divergence from the reported profitability metrics. While the DuPont decomposition reveals a robust return on equity of 14.0% driven primarily by expansive net margins at 27.0%, this operational leverage is counterbalanced by a negative ROIC-WACC spread of -1.9%. This indicates that despite high margin generation, the cost of capital currently exceeds the returns generated on invested assets, suggesting potential inefficiencies in asset utilization relative to financing costs. However, fundamental quality signals remain strong; the company exhibits a Piotroski F-Score of 7/9 and an Altman Z-Score of 7.5, indicating robust financial health with low distress probability, while revenue growth accelerates at 28.4% year-over-year.
Valuation dynamics appear stretched relative to intrinsic value models but are supported by recent insider positioning. The current P/E ratio of 20.2x sits significantly above the DCF-derived fair value estimate of $57 per share, implying that market pricing assumes a growth trajectory or margin expansion not fully captured in the base case model. This premium valuation is partially offset by substantial insider conviction, evidenced by $5.4 million in net buying over the last 90 days, which often signals management confidence in future operational execution despite current capital efficiency headwinds.
Risk assessment relies heavily on the quality of earnings and the sustainability of margin expansion given the negative spread between returns and cost of capital. The low Beneish M-Score of 1.16 suggests a lower likelihood of financial statement manipulation, reinforcing the credibility of the reported 27.0% net margins. Investors must weigh whether the high growth rate can eventually compress asset turnover or leverage requirements enough to turn the ROIC-WACC spread positive, thereby aligning current valuation multiples with long-term cash flow generation capabilities.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 11.4% | 13.4% | 15.4% |
|---|---|---|---|
| 2% | $65 | $53 | $44 |
| 3% | $71 | $57 | $47 |
| 4% | $79 | $61 | $50 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=13.4%, terminal growth 3%. Fair value $57 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
PAAS.TO Capital Efficiency
How efficiently does PAAS.TO convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
PAAS.TO converts 57% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. However, the ROIC-WACC spread is negative (-1.9%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare PAAS.TO to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.